News

Article

Psychedelics Beyond Clinical Settings Poll

Author(s):

Psychiatric Times Editors

Answer a quick question on psychedelics!

Have your patients shared or expressed interest in psychedelics for therapeutic purposes outside of clinical settings?

Yes, patient(s) have shared their interest
No, patient(s) have not talked about it
Related Videos
Tasphong/AdobeStock
Andrii Yalaanskyi/AdobeStock
Jorm Sangsorn/AdobeStock
RolfImages/AdobeStock
CravenA/AdobeStock
brain
Related Content
clinical trial
April 21st 2025

MindMed Begins Phase 3 Emerge Study of MM120 in Patients With Major Depressive Disorder

Grace Koennecke
Here's to a Psychedelic Revolution
April 9th 2022

Here's to a Psychedelic Revolution

Amir Inamdar MBBS, DNB (Psych), MFPM
Psychiatric Times Through the Years: The Last 5 Years in February Covers
February 22nd 2025

Psychiatric Times Through the Years: The Last 5 Years in February Covers

Megan McSweeney
David Hellerstein, MD: Psychedelic Treatments for Psychiatric Disorders
April 6th 2021

David Hellerstein, MD: Psychedelic Treatments for Psychiatric Disorders

Angela A. Coombs, MD Jennifer Sotsky, MD, MS
psychedelic
February 10th 2025

CYB003 for the Adjunctive Treatment of Major Depressive Disorder

Leah Kuntz
Pakin/Adobe Stock
December 31st 2024

ACNP Attendees Reflect on 2024 and Look Forward to 2025

Megan McSweeney
© 2025 MJH Life Sciences

All rights reserved.